Infection risk?: Ms does not cause increased risk of infection unless you were to reach severe end-stage debility. This of course can be prevented by use of potent disease modifying drugs, such as tysabri (natalizumab), (natalizumab) gilenya, or tecfidera. Aubagio has been associated with tuberculosis, Gilenya with herpes, tysabri (natalizumab) with pml, but none of the usual agents seem to increase risk of c. Diff.
Answered 6/25/2014
4.9k views
4 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question